What is Pigmented villonodular synovitis

Pigmented villonodular synovitis (PVNS), now frequently referred to as Tenosynovial Giant Cell Tumor (TGCT), is a rare, non-cancerous tumor that causes the lining of the joints or tendon sheaths to thicken and overgrow. While it is benign, the condition can be locally aggressive, causing significant joint pain, swelling, and potential damage to the surrounding bone and cartilage if left untreated.

What exactly is Pigmented villonodular synovitis?

Pigmented villonodular synovitis is a proliferative disorder affecting the synovium—the thin, protective membrane that lines our joints and tendon sheaths. In individuals with Pigmented villonodular synovitis, this lining becomes inflamed and produces excess tissue. This tissue can invade the joint space, erode adjacent bone, and cause chronic stiffness. Because the condition involves the buildup of iron-rich pigments (hemosiderin) within the tissue, it earned the name "pigmented," while "villonodular" refers to the finger-like (villi) and knot-like (nodular) appearance of the growths.

How is this condition classified and who does it affect?

Clinicians generally divide Pigmented villonodular synovitis into two primary types based on the area involved:

• Localized type: Affects a small, specific area, often found in the fingers or toes. This is more common in the tendon sheaths.


• Diffuse type: Involves the entire lining of a larger joint, most commonly the knee, followed by the hip, ankle, and shoulder. This form is more aggressive and has a higher rate of recurrence.

Regarding prevalence, Pigmented villonodular synovitis is very rare, with an estimated incidence of approximately 1.8 to 11 cases per million people per year. It typically presents in adults between the ages of 20 and 50, though it can occur at any age. There is no significant gender predilection, and it appears to occur globally without strong geographic or ethnic clustering.

What is the underlying cause of Pigmented villonodular synovitis?

The exact cause of Pigmented villonodular synovitis remains a subject of ongoing research. Current medical consensus suggests it is likely a neoplastic process—meaning it behaves similarly to a tumor—rather than a simple inflammatory reaction. A key finding in many cases is a chromosomal translocation involving the CSF1 gene. This genetic mutation triggers the overproduction of colony-stimulating factor 1 (CSF1), which attracts inflammatory cells to the joint, leading to the characteristic swelling and tissue overgrowth seen in Pigmented villonodular synovitis.

How does it differ from other joint conditions?

It is common for patients to initially mistake the symptoms of Pigmented villonodular synovitis for more common conditions like osteoarthritis or rheumatoid arthritis. However, several key factors help differentiate it:

1. Localized Swelling: Unlike the generalized inflammation of rheumatoid arthritis, this condition often presents as persistent, localized swelling in a single joint.


2. Imaging Findings: On MRI, Pigmented villonodular synovitis often shows "blooming" artifacts caused by the iron deposits (hemosiderin), a signature look that radiologists use to distinguish it from other masses.


3. Joint Destruction: Despite being benign, it can cause "pressure erosions" on the bone, which are distinct from the inflammatory bone erosions seen in autoimmune diseases.

At DiseaseMaps.org, 31 community members have connected to share their experiences with this rare diagnosis, highlighting the importance of specialized care.

Next steps

• Consult an orthopedic surgeon who specializes in musculoskeletal oncology or joint preservation.


• Request an MRI of the affected joint, as it is the gold standard for diagnostic imaging of this condition.


• Seek a second opinion from a center of excellence if your local provider is unfamiliar with the management of rare synovial tumors.


• Join the DiseaseMaps community to connect with other patients and share information about treatment pathways.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Pigmented villonodular synovitis (ORPHA:3335)


• NIH Genetic and Rare Diseases Information Center (GARD): Tenosynovial giant cell tumor


• OMIM (Online Mendelian Inheritance in Man): #192600 (Tenosynovial Giant Cell Tumor)


• Journal of the American Academy of Orthopaedic Surgeons: Clinical Management of TGCT/PVNS